Genosco

Genosco is a leader in the discovery and development of novel small molecule drugs to treat human diseases having the greatest un-met medical need utilizing a highly targeted approach. The company has utilized its proprietary Master Scaffolds to develop novel pharmaceuticals in a number of therapeutic areas, including inflammation, cancer and Parki... nson's diseases. The company's drug discovery group is a highly integrated interdisciplinary team of scientists with expertise in medicinal chemistry, structural and computational drug discovery design, cell biology, pharmacology and drug metabolism. Currently, the company has discovered the several master scaffolds selectively inhibiting protein kinases-enzymes that transfer phosphate groups to proteins, and are key players in virtually all signal pathways. There are about 518 kinases encoded in the human genome, many of them implicated in human diseases. Currently the company is working actively on SYK, EGFRm+, FGFR4, LRRK2 and FLT3 kinase targets with highly selective and potent inhibitors. The company's vision: is to deliver meaningful new drugs to patients. The company's mission: is to discover, develop, commercialize small molecule drugs to treat patients-where the current therapies are inadequate.Read More